EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Pre-Formulation Studies and Analytical Techniques in Pharmaceutical Formulation Development

    Development of pharmaceutical formulations is a very important phase in the drug development process which lies between a drug molecule that is discovered and a dose form that can be commercially developed It is a process that involves designing optimizing and validating drug products to make sure that they are safe effective and able to be taken by patients Preformulation studies form a significa...

    How Quantum Computing Is Transforming Drug Discovery

    The current medical setting sees technology lead drug development towards faster speeds Quantum computing in drug discovery belongs to an exclusive group of technological advances that drives revolutionary change in science The advanced computational model called quantum computing drives innovation in drug discovery as well as drug testing and pharmaceutical market release Scientists and experts n...

    Fundamentals of Clinical Pharmacology: Understanding Drug Actions and Ensuring Safety

    Clinical pharmacology offers the interface between the philosophies of pharmacology and its application in the actual sense in patient care Fundamentally it is the science which examines the activities of drugs how drugs communicate with biological systems and how such communications result in treatment outcomes or adverse events Clinical pharmacology principles are needed to make sense of how m...

    Building Resilient Pharma Supply Chains to Strengthen Patient Care

    The failure to deliver a temperaturesensitive biologic or a critical maintenance drug on time is becoming a patient outcome crisis not just an operational inefficiency By fortifying our global logistics networks we proactively safeguard the availability of lifesaving therapies and essential healthcare supplies securing the healthcare industrys central promise to global health This strategic impera...

    Exploring the Benefits of Bioassay in Pharmacology

    Pharmacology the study of drugs and their effects on living organisms is a multifaceted field crucial to the development and improvement of pharmaceuticals Bioassay a method that assesses the potency of substances

    Biopharmaceutical Facility Design for Sustainability: A Comprehensive Overview

    The design and operation of biopharmaceutical facilities play a pivotal role in shaping the environmental impact of the pharmaceutical industry In recent years there has been a growing emphasis on sustainability within this sector

TOP ARTICLES

  • 1

    How Quantum Computing Is Transforming Drug Discovery

    Kate Williamson

    The development of pharmaceuticals gets revolutionized through quantum computing because it permits expedited molecule simulations and exact drug development. Research teams using new quantum algorith...

  • 4

    Exploring the Benefits of Bioassay in Pharmacology

    Harry Callum

    Bioassays, integral to pharmacology, assess drug effects on living organisms. In vitro assays use isolated cells, aiding early drug screening, mechanism understanding, and target validation. In vivo a...

press releases Read more...

Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Ionis Pharmaceuticals Inc Nasdaq IONS partner Novartis today announced that the pelacarsen Phase LpaHORIZON study a pioneering cardiovascular outcomes trial did not meet its primary endpoint

Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Novartis today announced that the pelacarsen phase III LpaHORIZON trial a pioneering cardiovascular outcomes study did not meet its primary endpoint of reducing the risk of cardiovascular events a composite

Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy

Climb Bio Inc Nasdaq CLYM a clinicalstage biotechnology company developing therapeutics for patients with immunemediated diseases today announced positive initial data from the ongoing

Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program

Applied Biologics a biopharmaceutical company advancing novel therapies for serious diseases with significant unmet medical needs today announced an important preclinical milestone in its DiseaseModifying

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

AtomVie opens new radiopharmaceutical manufacturing facility in Ontario

AtomVie Global Radiopharma AtomVie has opened a new purposebuilt radiopharmaceutical manufacturing facility in Hamilton Ontario strengthening its capacity to support drug development and commercial production

Acepodia receives FDA clearance for ACE723 antibody-drug conjugate

Acepodia a clinicalstage biotechnology company developing cell therapies and antibodydrug conjugates ADCs has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ACE

Kali Therapeutics Receives U.S. FDA Clearance for KT501 Clinical Trial

Kali Therapeutics a clinicalstage biotechnology company developing immuneresetting and multispecific therapies has received clearance from the US Food and Drug Administration FDA for its Investigational New

Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development

Genedata has expanded its collaboration with Abcam to strengthen antibody development and support the use of artificial intelligence AI across Abcams global research and development operations

Evotec and Plectonic Enter Research Collaboration to Explore New T-Cell-Engaging Approaches for Solid Tumours

Evotec SE and Plectonic Biotech have entered a research collaboration to explore a new immunotherapy approach for solid tumours The partnership will combine Plectonics programmable LOGIBODY

NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy

NewBiologix SA and Synastra Biotechnology Inc have entered into an agreement to develop a stable producer cell line for Synastras investigational gene therapy programme for Duchenne muscular dystrophy DMD